Paper6437366
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
Prien RF and 6 others. Arch Gen Psychiatry, 1984. Cited by 543 papers, by iCite.
Cite this record
ConductScience Library. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Papers, record 6437366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6437366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bipolar Disorder | Major topic |
| Depressive Disorder | Major topic |
| Imipramine | Major topic |
| Lithium | Major topic |
| Actuarial Analysis | |
| Adult | |
| Ambulatory Care | |
| Clinical Trials as Topic | |
| Drug Therapy, Combination | |
| Female | |
| Hospitalization | |
| Humans | |
| Lithium Carbonate | |
| Male | |
| Middle Aged | |
| Outcome and Process Assessment, Health Care | |
| Psychiatric Status Rating Scales | |
| Recurrence |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| MH 29618 | NIMH NIH HHS | United States | R01MH029618 | PubMed and NIH | NIH RePORTER |
| MH 29683 | NIMH NIH HHS | United States | PubMed | PubMed | |
| MH 29690 | NIMH NIH HHS | United States | PubMed | PubMed | |
| R10MH029618 | NIH | NIH RePORTER | |||
| R37MH029618 | NIH | NIH RePORTER | |||
| U01MH029618 | NIH | NIH RePORTER |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 543 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41856598 | Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocol. | BMJ Open | 2026 | https://conductscience.org/library/papers/41856598 | PubMed |
| 36269510 | Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review. | CNS Drugs | 2022 | https://conductscience.org/library/papers/36269510 | PubMed |
| 34980362 | Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses. | Eur Neuropsychopharmacol | 2022 | https://conductscience.org/library/papers/34980362 | PubMed |
| 33174452 | Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis. | Can J Psychiatry | 2021 | https://conductscience.org/library/papers/33174452 | PubMed |
| 32402075 | Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines. | Int J Neuropsychopharmacol | 2020 | https://conductscience.org/library/papers/32402075 | PubMed |
| 30041458 | A History of the Pharmacological Treatment of Bipolar Disorder. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30041458 | PubMed |
| 29536616 | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. | Bipolar Disord | 2018 | https://conductscience.org/library/papers/29536616 | PubMed |
| 27816941 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm. | Int J Neuropsychopharmacol | 2017 | https://conductscience.org/library/papers/27816941 | PubMed |
| 26979387 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. | J Psychopharmacol | 2016 | https://conductscience.org/library/papers/26979387 | PubMed |
| 26152228 | Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials. | Int J Neuropsychopharmacol | 2015 | https://conductscience.org/library/papers/26152228 | PubMed |
| 24363691 | GABA A Receptors in the Dorsal Hippocampus are Involved in Sate-dependent Learning Induced by Lithium in Mice. | Iran J Pharm Res | 2011 | https://conductscience.org/library/papers/24363691 | PubMed |
| 24030475 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. | Am J Psychiatry | 2013 | https://conductscience.org/library/papers/24030475 | PubMed |
| 23726151 | Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. | Biol Psychiatry | 2013 | https://conductscience.org/library/papers/23726151 | PubMed |
| 22622948 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. | Eur Arch Psychiatry Clin Neurosci | 2012 | https://conductscience.org/library/papers/22622948 | PubMed |
| 22296314 | Studies of long-term use of antidepressants: how should the data from them be interpreted? | CNS Drugs | 2012 | https://conductscience.org/library/papers/22296314 | PubMed |
| 22070611 | Refractoriness in bipolar disorder: definitions and evidence-based treatment. | CNS Neurosci Ther | 2012 | https://conductscience.org/library/papers/22070611 | PubMed |
| 22033583 | General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. | Eur Arch Psychiatry Clin Neurosci | 2011 | https://conductscience.org/library/papers/22033583 | PubMed |
| 22033232 | Bipolar disorder. | Dialogues Clin Neurosci | 1999 | https://conductscience.org/library/papers/22033232 | PubMed |
| 21927496 | Lithium psychiatry : therapeutic efficacy, side effects and practical issues. | Indian J Psychiatry | 1991 | https://conductscience.org/library/papers/21927496 | PubMed |
| 21435226 | Class effect of pharmacotherapy in bipolar disorder: fact or misbelief? | Ann Gen Psychiatry | 2011 | https://conductscience.org/library/papers/21435226 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6437366
GET https://conductscience.org/api/papers/v1/6437366/cited_by?page=2